FDA drug-plant inspections still haven’t recovered from the pandemic, AP reports
Fast CompanyAs COVID-19 swept across the globe in early 2020, the Food and Drug Administration (FDA) pulled most of its safety inspectors from the field, creating a massive backlog of uninspected pharmaceutical plants in the U.S. and overseas.
Nearly five year…